Showing posts with label nociception. Show all posts
Showing posts with label nociception. Show all posts

Friday, November 28, 2025

Discovery of a new nerve 'pain switch' outside cells

Amazing stuff!

"In a major brain science breakthrough, New Orleans-based researchers and collaborators have discovered a nerve signaling mechanism that takes place outside the cell, flipping on a 'pain switch.' This significantly updates the way we understand how pain receptors work in the brain, and it could shed light on a path to safer pain medication that can effectively provide relief without the usual side effects. ...

They found that nerve cells communicate outside the cell with an enzyme called vertebrate lonesome kinase (VLK); this enzyme alters proteins in the space between neurons. When active neurons release VLK, it boosts the function of a pain receptor. ..."

"... The researchers found that mice genetically engineered to lack VLK in sensory neurons involved in pain did not develop acute hypersensitivity to pain after surgery. Conversely, administering VLK to normal mice induced robust pain hypersensitivity that was mediated by NMDA receptor activation. ..."

From the editor's summary and abstract:
"Editor’s summary
In the brain, extracellular kinases are responsible for phosphorylating the extracellular domain of proteins involved in synaptic transmission. Srikanth et al. focused on the mechanism of action of the synaptic kinase VLK (vertebrate lonesome linase) in sensory neurons. VLK is released from presynaptic sites and phosphorylates the extracellular domain of ephrin-B receptor kinases, thereby promoting the clustering of N-methyl-D-aspartic acid receptors (NMDARs) at synapses. Furthermore, VLK appears indispensable for neuronal viability and plays a crucial role in NMDAR-dependent injury-induced pain. These results suggest that VLK-mediated signaling might be targeted for managing NMDAR-dependent pain. ...

Structured Abstract
INTRODUCTION
Protein phosphorylation is a central mechanism of intracellular regulation, but its function outside the cell remains poorly understood. Although the secreted milk protein casein was shown to be phosphorylated more than a century ago in the 1880s, the biological relevance of extracellular phosphorylation has remained largely unexplored.
Recent studies have identified two families of secreted kinases and revealed that many synaptic proteins are phosphorylated in their extracellular domains. However, whether such phosphorylation events modulate synaptic signaling or behavior in vivo has remained an open question.

RATIONALE
We sought to define a role for extracellular phosphorylation in regulating receptor interactions at synapses. Specifically, we tested whether a secreted kinase could control the interaction between the receptor tyrosine kinase EphB2 and the N-methyl-d-aspartate receptor (NMDAR), a key regulator of glutamate signaling, and pain. Because EphB2 extracellular phosphorylation at the evolutionarily conserved tyrosine Y504 is required for binding to the NMDAR, we asked whether this modification might be controlled by secreted tyrosine kinases, and whether this signaling could modulate pain behaviors in vivo. Our goal was to define a synaptic signaling pathway linking presynaptic activity to extracellular receptor phosphorylation and downstream NMDAR function.

RESULTS
We identified vertebrate lonesome kinase (VLK/Pkdcc) as the only member of a six-gene ectokinase family that is both secreted and sufficient to induce EphB2–NMDAR interaction.
VLK phosphorylated EphB2 at Y504 in an ATP-dependent manner, and this effect was blocked by extracellular phosphatase and absent with VLK-kinase–dead mutants. Recombinant VLK (rVLK) induced EphB2–NMDAR complex formation in cultured neurons and spinal tissue, whereas Pkdcc knockout abolished the interaction. VLK localized to synaptic vesicles and was released in a SNARE-dependent manner following ephrin-B stimulation or elevated neuronal activity, consistent with regulated synaptic release.
In vivo, conditional deletion of Pkdcc from presynaptic sensory neurons disrupted EphB2 phosphorylation and prevented EphB2–NMDAR interaction in dorsal horn projection neurons after injury, without altering baseline expression of either protein.
Mice lacking VLK in sensory neurons failed to develop mechanical hypersensitivity following surgical injury but retained normal motor coordination and responses to heat and chemical stimuli.
Intrathecal injection of rVLK induced EphB2–NMDAR interaction and pain-like behaviors, and this effect required NMDAR activity.
Postsynaptic deletion of EphB2 in spinothalamic neurons blocked injury-induced pain behaviors, confirming the necessity of this signaling pathway for pain sensitization.

CONCLUSION
Our findings reveal an extracellular phosphorylation pathway that links presynaptic activity to postsynaptic receptor organization and behavior.
By releasing a kinase that acts on the outside of the postsynaptic membrane, neurons can modulate NMDAR function in a spatially and behaviorally specific manner—without invoking canonical intracellular pathways—highlighting an underappreciated dimension of synaptic signaling that occurs in the extracellular space. Given the essential role of NMDARs in synaptic plasticity and the embryonic lethality of neuronal VLK knockout, this pathway likely extends beyond pain and may offer new therapeutic opportunities for modulating receptor function."

New brain science finds a nerve 'pain switch' outside cells


Tulane scientists uncover new pain-signaling switch (original news release 2)




A synaptic ectokinase induces the EphB2–NMDAR interaction and mechanical hypersensitivity.


Fig. 1 VLK is sufficient to induce the EphB2-NMDAR interaction.


Two of the study's authors: Hajira Elahi & Ted Price


Saturday, April 05, 2025

Immune cells have unexpected role in fighting pain, but only in female mice

Amazing stuff!

A case of sex discrimination in nature! I will call my attorney!😊 Just kidding!

"Unlike the combative immune cells that protect us from pathogens, regulatory T cells (Tregs) are nurturers. They salve inflammation, promote healing of injured tissue, and rein in immune attacks to curb self-inflicted damage.
Now, a study of mice ... suggests some Tregs also act on nerve cells to quell a specific type of pain—but only in females. Why only female rodents seem to benefit remains unclear, but researchers hope they might someday enlist these Tregs to address pain conditions, many of which disproportionately affect women. ..."

From the editor's summary and abstract:
"Editor’s summary
Regulatory T (Treg) cells play a well-defined role in restraining inflammatory immune responses. Midavaine et al. found that depleting Treg cells specifically localized to the meninges of the central nervous system (mTreg cells) increased the responses of female, but not male, mice to mechanical pain stimuli.
These mTreg cells were a source of enkephalin, an endogenous opioid peptide, within the cerebrospinal fluid.
In the context of nerve injury, the enkephalin associated with mTreg cells could decrease pain sensing by activating the δ-opioid receptor expressed by a subset of nociceptive neurons involved in mechanical pain sensing.
Injecting the cytokine interleukin-2 (IL-2) into the spinal fluid increased mTreg cell numbers and decreased mechanical pain sensing in female mice after nerve injury. The analgesic effect of IL-2 in female mice could be prevented by blocking female sex hormones. ...

Abstract
T cells have emerged as orchestrators of pain amplification, but the mechanism by which T cells control pain processing is unresolved.
We found that regulatory T cells (Treg cells) could inhibit nociception through a mechanism that was not dependent on their ability to regulate immune activation and tissue repair.
Site-specific depletion or expansion of meningeal Treg cells (mTreg cells) in mice led to female-specific and sex hormone–dependent modulation of mechanical sensitivity. Specifically, mTreg cells produced the endogenous opioid enkephalin that exerted an antinociceptive action through the delta opioid receptor expressed by MrgprD+ sensory neurons.
Although enkephalin restrains nociceptive processing, it was dispensable for Treg cell–mediated immunosuppression.
Thus, our findings uncovered a sexually dimorphic immunological circuit that restrains nociception, establishing Treg cells as sentinels of pain homeostasis."

Immune cells have unexpected role in fighting pain | Science | AAAS "Inflammation-suppressing regulatory T cells reduce pain in female mice by targeting nerve cells"

[I was unable to find an original news release for this discovery!]



Regulatory T cells (pink) in membranes near the mouse spinal cord send pain-suppressing signals to nerves.


Tuesday, March 11, 2025

With chronic pain comes depression and anxiety in particular for younger people

Bad news!

"Medical researchers are calling for changes in the treatment of chronic pain, with more routine screening for depression and anxiety among patients.

It comes after a systematic review of the literature found that about 40% of adults living with chronic pain also have clinical depression or anxiety. ...

It found that the prevalence of depression and anxiety was highest among women, younger people, and individuals with “nociplastic” chronic pain, like fibromyalgia, complex regional pain syndrome, and temporal mandibular disorder. ..."

From the key points and abstract:
"Key Points
Question
How prevalent are depression and anxiety among adults with chronic pain?
Findings 
This systematic review and meta-analysis identified 376 studies comprising 347 468 individuals with chronic pain from 50 countries, with a pooled prevalence of 39.3% for depression and 40.2% for anxiety; the prevalences were highest among samples of people with fibromyalgia and samples of people who were younger and predominantly female. The prevalences of depression and anxiety were significantly higher among individuals with chronic pain than in both clinical and nonclinical control groups.
Meaning 
This study suggests that the prevalences of depression and anxiety among adults with chronic pain are approximately 40%; to address this significant public health concern, it is essential to routinely screen for mental health symptoms in clinical settings where people with chronic pain are treated.

Abstract
Importance
Depression and anxiety are common among adults with chronic pain, but their prevalence is unclear.
Objectives
To evaluate the prevalence of depression and anxiety among adults with chronic pain and identify factors that moderate prevalence.
Data Sources
A literature search was conducted of MEDLINE, Embase, PsycINFO, and Cochrane Library from January 2013 to October 2023.
Study Selection
Studies reporting the prevalence of depression or anxiety using a validated assessment tool among adults with chronic pain (excluding chronic headache disorders).
Data Extraction and Synthesis
A total of 31 159 initial records were identified, and 5177 full texts were screened. Data were extracted per the Preferred Reporting Items for Systematic Reviews and Meta-analyses guideline using Covidence. Two independent reviewers completed abstract screening, full-text review, and data extraction and rated risk of bias. Random-effects meta-analyses were applied to pool prevalence, assess moderation, and compare prevalence of depression or anxiety among samples with chronic pain vs control samples.
Main Outcomes and Measures
Prevalence of depression and anxiety based on clinically significant symptoms or diagnosis. The moderators of prevalence identified were pain condition, recruitment setting, continent, age, percentage female, and pain duration.
Results
The search identified 376 studies from 50 countries comprising 347 468 individuals (mean [SD] age, 51.3 [9.5] years; 70.0% female) with chronic pain. Among adults with chronic pain, clinical symptoms of depression were present in 39.3% (95% CI, 37.3%-41.1%; I2 = 98.9%), and clinical symptoms of anxiety were present in 40.2% (95% CI, 38.0%-42.4%; I2 = 99.0%).
Prevalence differed by pain condition (highest among samples of people with fibromyalgia [depression, 54.0% (95% CI, 48.5%-59.4%); anxiety, 55.5% (95% CI, 50.4%-60.4%)]; lowest among samples of people with arthritis conditions [eg, osteoarthritis: depression, 29.1% (95% CI, 20.3%-39.7%); anxiety, 17.5% (95% CI, 6.6%-38.8%)]) and was highest among younger people (depression, β = −0.02 [95% CI, −0.03 to −0.01]; anxiety, β = −0.02 [95% CI, –0.03 to –0.01]) and women (depression, β = 0.69 [95% CI, 0.31-1.08]; anxiety, β = 0.90 [95% CI, 0.48-1.33]). With regard to diagnoses, 36.7% (95% CI, 29.0%-45.1%) had a major depressive disorder, and 16.7% (95% CI, 11.8%-23.2%) had generalized anxiety disorder. Women, younger people, and people with nociplastic pain (ie, pain arising from altered nociception without tissue damage) were most likely to have depression and anxiety.
Conclusions and Relevance
In this systematic review and meta-analysis of depression and anxiety among individuals with chronic pain, approximately 40% of adults had clinically significant depression and anxiety. Women, younger people, and people with nociplastic pain were most likely to have depression and anxiety. The co-occurrence of chronic pain with depression and anxiety is a significant public health concern necessitating routine screening in clinical settings, equitable access to specialty care, and innovative treatment development."

With chronic pain comes depression and anxiety

Worldwide Study Finds High Rates of Depression and Anxiety in People with Chronic Pain "A Systematic Review and Meta-Analysis" (original news release)

Sunday, January 15, 2023

Insects may feel pain after all (or a misleading popular science article)

Next time you swat a mosquito keep that in mind! 😊

Unfortunately, I did not realize that this recent popular science article is based on pretty old studies with the most recent ones dating to July 2022. It even quotes a Smithsonian Magazine article from July 2019 titled "Study Finds Insects Can Experience Chronic Pain"

"... Most animals (if not all) exhibit something called nociception — a physical reaction to harm that is useful (it helps the animal avoid what is harmful) — but this is not exactly pain per se. ...
Until not very long ago, it was thought that only humans and some mammals can feel pain. Increasingly, though, researchers found out that way more animals can feel pain. Fish are one good example: for a long time, we thought fish couldn’t feel pain, but research has shown that that’s not really the case. ...
the insects’ nervous systems. They started by drawing comparisons with humans. ... This is because sometimes, in an emergency, the brain produces opiates that hijack the brain and prevent it from feeling pain.
Insects don’t really produce opiates, but they produce neuropeptides, which are substances that serve a similar purpose. Researchers found that when insects were exposed to physical trauma, they seem to produce neuropeptides, mimicking how humans and other vertebrates produce opiates, which is possible evidence of them feeling pain. ...
This isn’t the first time researchers have found evidence of feeling pain. In 2019, one study showed that insects can experience chronic pain and, increasingly, evidence is mounting that insects may be more sentient than we thought. ..."

Insects may feel pain after all, and may be more sentient than we thought We do a lot of bad things to insects, and we shrug it off by thinking insects don't feel any pain. But that may not be true.